NUPLAZID:
Real help for a real part of Parkinson’s disease

NUPLAZID® (pimavanserin) is the first and only medicine FDA-approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

Did you know that over 50% of people living with Parkinson’s will experience hallucinations or delusions over the course of their disease?

Facts about NUPLAZID

  • clock

    NUPLAZID works around the clock to help reduce Parkinson’s disease hallucinations and delusions

    NUPLAZID works all day and night to help reduce hallucinations and delusions associated with Parkinson’s disease psychosis. You just take two 17‑mg tablets, once a day, at a time that you choose, or as prescribed by your doctor. It’s important to remember that everyone responds to medications differently, so it may take some time for NUPLAZID to start working.

  • clock

    Continuing to take NUPLAZID as prescribed may help you see results

    NUPLAZID may begin to reduce hallucinations and delusions as soon as 2 weeks, but it may take up to 6 weeks to feel the full effect. You should speak with your doctor before you stop taking NUPLAZID.

  • chart - downward trend

    NUPLAZID significantly reduced the number and/or severity of symptoms in the majority of people

    In a clinical trial, the majority of people who took NUPLAZID experienced fewer and/or less severe symptoms. And, after 6 weeks, some people were no longer experiencing any symptoms. Not everyone will respond to NUPLAZID.

    To test the effectiveness of NUPLAZID, an FDA-accepted tool was used. The tool measures changes in the frequency or severity of hallucinations and delusions in people with Parkinson’s.

    Tell me more about the trial X

    The clinical trial included 199 adults (at least 40 years of age with a mean age of 72 years) diagnosed with Parkinson’s disease psychosis that was severe enough for treatment. It was a randomized, double-blind, placebo-controlled study. Each person was assigned to 1 of 2 groups: those who received NUPLAZID or those who received placebo. Results were reported after 6 weeks.

  • pills

    Taking NUPLAZID doesn’t require adjusting doses of carbidopa/levodopa

    You can take NUPLAZID without adjusting doses of carbidopa/levodopa medicines. Some medicines should not be taken with NUPLAZID. Tell your doctor about all of the medicines you are taking.

  • stop! (hand)

    NUPLAZID has no effect on motor symptoms

    Taking NUPLAZID did not affect motor symptoms during a clinical trial.

Back to top

Important Safety Information and Indication for NUPLAZID (pimavanserin) 17-mg Tablets

Increased risk of death in elderly patients with dementia-related psychosis. Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson's disease psychosis. Continues below

Do not take NUPLAZID if you have had an allergic reaction to any of the ingredients in NUPLAZID. Allergic reactions have included rash, hives, throat tightness, and swelling of the tongue, mouth, lips, or face.

NUPLAZID may cause serious side effects including:
QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to prolong the QT interval. Tell your healthcare provider about all the medicines you take or have recently taken.

Do not take NUPLAZID if you have certain heart conditions that change your heart rhythm. It is important to talk to your healthcare provider about the possible side effect of changes to your heart rhythm. Call your healthcare provider if you feel a change in your heartbeat.

Before taking NUPLAZID, tell your healthcare provider if you have:

  • Reduced kidney function. NUPLAZID is not recommended if you have severe kidney problems.
  • Reduced liver function. NUPLAZID is not recommended if you have liver problems.

Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.

The most common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.

Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if NUPLAZID may harm your unborn baby.

It is not known if NUPLAZID is safe and effective in people under 18 years of age.

Dosage and Administration

The recommended dose of NUPLAZID is 34 mg once per day, taken as two 17-mg tablets.

Indication

NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088. You can also call ACADIA Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).

Please see full Prescribing Information including Boxed WARNING.

This website is intended for use by US residents.

Important Safety Information and Indication for NUPLAZID (pimavanserin) 17-mg Tablets

Increased risk of death in elderly patients with dementia-related psychosis. Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson's disease psychosis. Continues below

Do not take NUPLAZID if you have had an allergic reaction to any of the ingredients in NUPLAZID. Allergic reactions have included rash, hives, throat tightness, and swelling of the tongue, mouth, lips, or face.

NUPLAZID may cause serious side effects including:
QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to prolong the QT interval. Tell your healthcare provider about all the medicines you take or have recently taken.

Do not take NUPLAZID if you have certain heart conditions that change your heart rhythm. It is important to talk to your healthcare provider about the possible side effect of changes to your heart rhythm. Call your healthcare provider if you feel a change in your heartbeat.

Before taking NUPLAZID, tell your healthcare provider if you have:

  • Reduced kidney function. NUPLAZID is not recommended if you have severe kidney problems.
  • Reduced liver function. NUPLAZID is not recommended if you have liver problems.

Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.

The most common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.

Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if NUPLAZID may harm your unborn baby.

It is not known if NUPLAZID is safe and effective in people under 18 years of age.

Dosage and Administration

The recommended dose of NUPLAZID is 34 mg once per day, taken as two 17-mg tablets.

Indication

NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088. You can also call ACADIA Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).

Please see full Prescribing Information including Boxed WARNING.

This website is intended for use by US residents.